This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Sonia Escaich
CEO at V4CURE
Presenter

Profile

V4Cure SAS is a biotech spin off from CEA, and incubated by Paris Biotech Santé. V4CURE received in 2022 the national ILAB grant for innovation with the Honor Award.Team is composed of pharma and life science professionals.V4Cure specializes in the discovery and therapeutic development of innovative peptides derived from animal venoms for new drugs in the cardio-renal field.Business model: To Develop our innovative drug candidates up to POC in clinical trial phase II and out licensing.

Agenda Sessions

  • “Take a Chance on Me” Startup spotlight pitch competition

    15:00